Can reduced imaging times be used for scintimammography?

Nuclear Medicine Communications

Volumn 20, Issue 10, 1999, Pages 883-886

  Clarke, E A ^a   Notghi, A ^a   Harding, L K ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONITRILE DERIVATIVE; METHOXYBUTYLISONITRILE TC 99M; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; LYMPH NODE METASTASIS; SCINTIMAMMOGRAPHY;

EID: 0032758609     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199910000-00003     Document Type: Article

References (7)

1. Khalkhali I, Mena I, louanne E et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178: 491-497.
2. Cwikla JB, Buscombe JR, Kelleher SM et al. Comparison of accuracy of scintimammography and x-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Clin Rad 1998; 53: 274-280.
3. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: A new role of prone scintimammography using technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 357-362.
4. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Scintigraphic imaging of breast cancer: A review. Nucl Med Commun 1997; 18: 698-709.
5. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995; 36: 1758-1765.
6. Khalkhali I, Cutrone JA, Mena IG et al. Scintimammo-graphy: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196: 421-426.
7. Mansi L, Rambaldi PF, Procaccini E et al. Scintimammo-graphy with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur J Nucl Med 1996; 23: 932-939.